Glaucoma persists as a leading cause of irreversible vision damage, but recent progresses in treatment have provided new hope for patients. Cutting-edge therapies, such as targeted drug delivery systems and minimally invasive surgical procedures, are emerging traction, aiming to protect vision by reducing intraocular pressure more effectively. Furt